Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03430154 · ClinicalTrials.gov registry record
Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)
A clinical trial of Haemophilia A, Haemophilia B, Obesity, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 317
- Enrollment target
- 1
- Study location
NCT03430154: Completed study of Haemophilia A, Haemophilia B, Obesity, sponsored by Novo Nordisk A/S.
NCT03430154 is a study of Haemophilia A, Haemophilia B, Obesity that has completed, run by Novo Nordisk A/S. The registered enrollment target is 317 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03430154, a study of Haemophilia A, Haemophilia B, Obesity, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 317 participants
- Enrollment target
- 1
- Study location
Study Summary
An online web-based cross-sectional survey in which participants will complete a distinct questionnaire for patients with hemophilia and obesity (PwHO) and/or their carers/spouses/partners, or a distinct questionnaire for healthcare professionals. Each questionnaire consists of more than 100 items including pre-coded (multiple choice) closed-ended questions, yes/no questions and rating scales. It is estimated that this one-off survey will take approximately 45-60 minutes to complete. As a cross-sectional study, there will be no treatment of patients.
Primary Outcome
Data is collected via online questionnaires
Conditions Studied
Interventions
- OTHER No treatment given
Study Locations (1)
New Jersey
- Novo Nordisk Investigational Site - Plainsboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 317 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2018-04-29 |
What the finished NCT03430154 record still lists
NCT03430154 is an observational study that tracks outcomes without assigning an intervention. The registered 317 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Haemophilia A, Haemophilia B, Obesity appearing as the primary indexed condition, and to 1 intervention - of which No treatment given is the first listed.
NCT03430154 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT03430154 about?
NCT03430154 is a clinical study titled "Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)". An online web-based cross-sectional survey in which participants will complete a distinct questionnaire for patients with hemophilia and obesity (PwHO) and/or their carers/spouses/partners, or a distinct questionnaire for healthcare professionals. Each questionnaire consists of more than 100 items i...
What is the current status of trial NCT03430154?
This trial is currently completed. The enrollment target is 317 participants. The study started on 2017-12-01. Estimated completion is 2018-04-29.
What conditions does trial NCT03430154 study?
This clinical trial studies the following conditions: Haemophilia A, Haemophilia B, Obesity.
What interventions are being tested in trial NCT03430154?
The interventions under investigation include: No treatment given (OTHER).
Who is sponsoring clinical trial NCT03430154?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03430154 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04594642 · 317 participants · Phase 1
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma
- NCT04977453 · 317 participants · Phase 1
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
- NCT05137054 · 317 participants · Phase 1
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
- NCT05382754 · 317 participants · NA
Home Apnea Testing in CHildren Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI